Axo Longevity Raises $5M Seed

Axo Longevity, based in London and Madrid, is a preventive health platform providing biomarker testing and personalized health blueprints. The company has raised $5M in a seed funding round to accelerate the expansion of its preventive health membership across international markets.

Investors

The round included participation from MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital, NIAN Sports & Entertainment, and angel investors Dr. Jorge Planas and Daniel Kulle.

Axo Longevity Use of Funds

The company plans to use the capital to grow its laboratory network, continue the development of its AI health copilot and wearable device integrations, and expand its services into the Nordics, Italy, and Portugal.

About Axo Longevity

Founded in 2025 by Andrew McCarthy, Sergio Tang, and Octavia Seymour, Axo Longevity is a global preventive health membership service. Its platform provides users with comprehensive blood panel analysis, biological age tracking, and personalized health action plans.

Funding Details

Company Website: https://axolongevity.com

Company: Axo Longevity
Raised: $5M
Round: Seed
Funding Date: September 15, 2026
Additional Investors: MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital, NIAN Sports & Entertainment, Dr. Jorge Planas, Daniel Kulle
Company Website: www.axolongevity.com
Software Category: HealthTech
Source: http://www.goskagit.com/spotlight/axo-longevity-raises-oversubscribed-5m-seed-round-to-build-europe-s-leading-preventive-health-membership/article_c774e7ba-3f15-577a-84cd-50a8b2a96ca5.html